JP2004534103A - ゲル組成物 - Google Patents

ゲル組成物 Download PDF

Info

Publication number
JP2004534103A
JP2004534103A JP2003512710A JP2003512710A JP2004534103A JP 2004534103 A JP2004534103 A JP 2004534103A JP 2003512710 A JP2003512710 A JP 2003512710A JP 2003512710 A JP2003512710 A JP 2003512710A JP 2004534103 A JP2004534103 A JP 2004534103A
Authority
JP
Japan
Prior art keywords
gel
gel composition
composition according
carbomer
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003512710A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004534103A5 (enExample
Inventor
テイラー、マーガレット・ジョアン
Original Assignee
デ・モントフォート・ユニバーシティ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by デ・モントフォート・ユニバーシティ filed Critical デ・モントフォート・ユニバーシティ
Publication of JP2004534103A publication Critical patent/JP2004534103A/ja
Publication of JP2004534103A5 publication Critical patent/JP2004534103A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/559—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody through a gel, e.g. Ouchterlony technique
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/548—Carbohydrates, e.g. dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Colloid Chemistry (AREA)
JP2003512710A 2001-07-10 2002-07-10 ゲル組成物 Withdrawn JP2004534103A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0116860.8A GB0116860D0 (en) 2001-07-10 2001-07-10 Gel compositions
PCT/GB2002/003183 WO2003006993A2 (en) 2001-07-10 2002-07-10 Gel compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011058397A Division JP5405511B2 (ja) 2001-07-10 2011-03-16 ゲル組成物

Publications (2)

Publication Number Publication Date
JP2004534103A true JP2004534103A (ja) 2004-11-11
JP2004534103A5 JP2004534103A5 (enExample) 2006-01-05

Family

ID=9918254

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003512710A Withdrawn JP2004534103A (ja) 2001-07-10 2002-07-10 ゲル組成物
JP2011058397A Expired - Fee Related JP5405511B2 (ja) 2001-07-10 2011-03-16 ゲル組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011058397A Expired - Fee Related JP5405511B2 (ja) 2001-07-10 2011-03-16 ゲル組成物

Country Status (9)

Country Link
US (1) US8247391B2 (enExample)
EP (1) EP1407267B1 (enExample)
JP (2) JP2004534103A (enExample)
AT (1) ATE513214T1 (enExample)
DK (1) DK1407267T3 (enExample)
ES (1) ES2368036T3 (enExample)
GB (1) GB0116860D0 (enExample)
PT (1) PT1407267E (enExample)
WO (1) WO2003006993A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0116860D0 (en) 2001-07-10 2001-09-05 Univ Montfort Gel compositions
DE10254636A1 (de) * 2002-11-22 2004-06-09 Capsulution Nanoscience Ag Verfahren zum Modifizieren von Mikropartikeln sowie Vorrichtung zum Modifizieren von Mikropartikeln
CA3066594A1 (en) * 2004-10-08 2006-04-20 Georgia Tech Research Corporation Microencapsulation of cells in hydrogels using electrostatic potentials
CN102325814B (zh) * 2009-01-14 2014-03-12 康奈尔大学 用于生物医学用途的生物可降解型水凝胶的制备
CN101745114B (zh) * 2009-12-25 2013-01-23 浙江工业大学 一种对葡萄糖敏感可自控释胰岛素的生物材料的制备方法
US20140350370A1 (en) * 2013-04-08 2014-11-27 The Texas A&M University System Glucose sensing assay
GB201310185D0 (en) 2013-06-07 2013-07-24 Univ Montfort Container
GB201314640D0 (en) * 2013-08-15 2013-10-02 Univ Montfort Matrix gel
CN113350489A (zh) 2015-04-21 2021-09-07 北卡罗来纳州立大学 使用缺氧敏感性纳米复合材料的葡萄糖响应性胰岛素递送系统
CN108366960B (zh) * 2015-10-23 2022-04-19 国立大学法人东京医科齿科大学 药物递送装置
WO2018085809A1 (en) 2016-11-07 2018-05-11 North Carolina State University Patch loaded with dual-sensitive vesicles for enhanced glucose-responsive insulin delivery
NO343313B1 (en) * 2017-03-15 2019-01-28 Lifecare As Fluid composition, method for preparing the composition and use
BR112021011103A8 (pt) * 2018-12-18 2022-08-09 Currahee Holding Company Inc Emplastro personalizado para aplicação tópica
US20220370493A1 (en) * 2019-06-04 2022-11-24 Thirty Holdings Limited Methods and compositions for generating nitric oxide and uses thereof
AU2020286987B2 (en) * 2019-06-04 2025-09-11 Thirty Respiratory Limited Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
TWI899548B (zh) * 2023-03-13 2025-10-01 羅怡情 染髮用凝膠的用途及製法
CN121243060B (zh) * 2025-11-07 2026-08-11 江苏知原药业股份有限公司 一种高稳定性的阿达帕林凝胶的制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07507268A (ja) * 1992-01-10 1995-08-10 デ　モントフォート　ユニヴァーシティ ドラッグシステム
JPH09501416A (ja) * 1993-06-30 1997-02-10 デ モントフォート ユニヴァーシティ 薬物システム
WO2001016575A1 (en) * 1999-08-27 2001-03-08 M-Biotech, Inc. Glucose biosensor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705503A (en) * 1986-02-03 1987-11-10 Regents Of The University Of Minnesota Metabolite sensor including a chemical concentration sensitive flow controller for a drug delivery system
DE4203466A1 (de) 1992-02-04 1993-08-05 Rudolf Prof Dr Ehwald Affinitaets-sensor
US5562917A (en) * 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
JP3536186B2 (ja) * 1995-02-27 2004-06-07 独立行政法人 科学技術振興機構 生体内分解性高分子ヒドロゲル
US5889028A (en) * 1996-02-09 1999-03-30 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
WO1998022097A2 (en) * 1996-11-20 1998-05-28 Bio Advances, Llc Controlled release matrix composition using polar polymer or monomer and poly(acrylic acid) blend
GB9805896D0 (en) 1998-03-20 1998-05-13 Eglise David Remote analysis system
CA2337667C (en) 1998-08-10 2008-04-29 Amgen Inc. Dextran-leptin conjugates, pharmaceutical compositions and related methods
GB0116860D0 (en) 2001-07-10 2001-09-05 Univ Montfort Gel compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07507268A (ja) * 1992-01-10 1995-08-10 デ　モントフォート　ユニヴァーシティ ドラッグシステム
JPH09501416A (ja) * 1993-06-30 1997-02-10 デ モントフォート ユニヴァーシティ 薬物システム
WO2001016575A1 (en) * 1999-08-27 2001-03-08 M-Biotech, Inc. Glucose biosensor

Also Published As

Publication number Publication date
GB0116860D0 (en) 2001-09-05
ATE513214T1 (de) 2011-07-15
PT1407267E (pt) 2011-09-19
EP1407267A2 (en) 2004-04-14
WO2003006993A2 (en) 2003-01-23
US8247391B2 (en) 2012-08-21
US20040265386A1 (en) 2004-12-30
WO2003006993A3 (en) 2003-09-25
JP5405511B2 (ja) 2014-02-05
EP1407267B1 (en) 2011-06-15
JP2011144197A (ja) 2011-07-28
ES2368036T3 (es) 2011-11-11
DK1407267T3 (da) 2011-09-19

Similar Documents

Publication Publication Date Title
JP5405511B2 (ja) ゲル組成物
Chen et al. Microneedle patches loaded with nanovesicles for glucose transporter-mediated insulin delivery
JP2023504853A (ja) 炎症応答性を有する抗炎症性ハイドロゲル
Simões et al. Modular hydrogels for drug delivery
Bernkop-Schnürch et al. Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine
Vandamme et al. Poly (amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide
Kim et al. Hyaluronate Epidermal Growth Factor Conjugate for Skin Wound Healing and Regeneration
Perrone et al. S-preactivated thiolated glycol chitosan useful to combine mucoadhesion and drug delivery
Sun et al. A pH‐sensitive chitosan‐tripolyphosphate hydrogel beads for controlled glipizide delivery
Deutel et al. Novel insulin thiomer nanoparticles: in vivo evaluation of an oral drug delivery system
Najafi et al. Conversion of an injectable MMP-degradable hydrogel into core-cross-linked micelles
CN110256669B (zh) 巯基/苯硼酸基修饰聚合物、葡萄糖敏感水凝胶组合物、葡萄糖敏感载药水凝胶及制备方法
Meng et al. Research progress on albumin-based hydrogels: Properties, preparation methods, types and its application for antitumor-drug delivery and tissue engineering
Sharma et al. Selection and role of polymers for designing of a drug carrier
Musazzi et al. Gellan nanohydrogels: novel nanodelivery systems for cutaneous administration of piroxicam
Paul et al. Improvement in insulin absorption into gastrointestinal epithelial cells by using molecularly imprinted polymer nanoparticles: microscopic evaluation and ultrastructure
Zhou et al. Glucose and pH dual-responsive polymersomes with multilevel self-regulation of blood glucose for insulin delivery
EP2120894A1 (en) Oral submicron particle delivery system for proteins and process for its production
CN108778318A (zh) 葡萄糖响应性胰岛素递送组合物和方法
US10675334B2 (en) Matrix gel
Zhang et al. Improving matrix metalloproteinase-2 specific response of a hydrogel system using electrophoresis
WO2007012876A1 (en) Hydrogel particle
SHARMA et al. Recent approaches in glucose responsive insulin delivery system
de Gomes Teixeira Surface-modified nanoparticles with novel peptides targeting the intestinal neonatal Fc receptor
Shahi et al. Polysaccharide-Based Nanocarriers for Oral Delivery of Proteins and Peptides: A Paradigm Shift in Biopharmaceutical Transport

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050519

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050519

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090414

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090714

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090722

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091009

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101116

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20110603